Rohit Virchandbhai Sathvara

Rohit Virchandbhai Sathvara

Active Director Director DIN 09530159
DIN 09530159 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohit Virchandbhai Sathvara

Data last updated:

Rohit Virchandbhai Sathvara is a Director at Zymeth Pharmacy Private Limited (since 2022). The company operates in Pharma.

DIN 09530159
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zymeth Pharmacy Private Limited U24290GJ2022PTC129933
Director08 Mar 20222022Active

Board colleagues of Rohit Virchandbhai Sathvara

NameDINCompanyDesignation
Pankaj Maganbhai Parmar08374085Zymeth Pharmacy Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zymeth Pharmacy Private Limited
Premium access

Shareholding and investment profile for Rohit Virchandbhai Sathvara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohit Virchandbhai Sathvara

Rohit Virchandbhai Sathvara currently holds 1 directorship: Zymeth Pharmacy Private Limited (Director, since 08 Mar 2022).

Rohit Virchandbhai Sathvara was first appointed on 08 Mar 2022 as Director at Zymeth Pharmacy Private Limited.

The current boards of Rohit Virchandbhai Sathvara's companies include Pankaj Maganbhai Parmar (Zymeth Pharmacy Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available